XERS Q1 2019 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$982M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$248,000-5.7% YoY

Gross Profit

$248,000100.0% margin

Operating Income

-$25M-10256.9% margin

Net Income

-$25M-10192.3% margin

EPS (Diluted)

$-1.07

QoQ Revenue Growth

-69.0%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$161M

Total Liabilities

$54M

Stockholders' Equity

$107M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$248,000	$263,000	-5.7%
Gross Profit	$248,000	$221,000	+12.2%
Operating Income	-$25M	-$12M	-116.9%
Net Income	-$25M	-$12M	-112.3%